PHSP-Net: Personalized Habitat-Aware Deep Learning for Multi-Center Glioblastoma Survival Prediction Using Multiparametric MRI.

IF 3.7 3区 医学 Q2 ENGINEERING, BIOMEDICAL
Tianci Liu, Yao Zheng, Chengwei Chen, Jie Wei, Dong Huang, Yuefei Feng, Yang Liu
{"title":"PHSP-Net: Personalized Habitat-Aware Deep Learning for Multi-Center Glioblastoma Survival Prediction Using Multiparametric MRI.","authors":"Tianci Liu, Yao Zheng, Chengwei Chen, Jie Wei, Dong Huang, Yuefei Feng, Yang Liu","doi":"10.3390/bioengineering12090978","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Glioblastoma (GBM) is a highly aggressive and heterogeneous primary malignancy of the central nervous system, with a median overall survival (OS) of approximately 15 months. Achieving accurate and generalizable OS prediction across multi-center settings is essential for clinical application.</p><p><strong>Methods: </strong>We propose a Personalized Habitat-aware Survival Prediction Network (PHSP-Net) that integrates multiparametric MRI with an adaptive habitat partitioning strategy. The network combines deep convolutional feature extraction and interpretable visualization modules to perform patient-specific subregional segmentation and survival prediction. A total of 1084 patients with histologically confirmed WHO grade IV GBM from four centers (UPENN-GBM, UCSF-PDGM, LUMIERE and TCGA-GBM) were included. PHSP-Net was compared with conventional radiomics, habitat imaging models and ResNet10, with independent validation on two external cohorts.</p><p><strong>Results: </strong>PHSP-Net achieved an AUROC of 0.795 (95% CI: 0.731-0.852) in the internal validation set, and 0.707 and 0.726 in the LUMIERE and TCGA-GBM external test sets, respectively-outperforming both comparison models. Kaplan-Meier analysis revealed significant OS differences between predicted high- and low-risk groups (log-rank <i>p</i> < 0.05). Visualization analysis indicated that necrotic-region habitats were key prognostic indicators.</p><p><strong>Conclusions: </strong>PHSP-Net demonstrates high predictive accuracy, robust cross-center generalization and improved interpretability in multi-center GBM cohorts. By enabling personalized habitat visualization, it offers a promising non-invasive tool for prognostic assessment and individualized clinical decision making in GBM.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 9","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467337/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12090978","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Glioblastoma (GBM) is a highly aggressive and heterogeneous primary malignancy of the central nervous system, with a median overall survival (OS) of approximately 15 months. Achieving accurate and generalizable OS prediction across multi-center settings is essential for clinical application.

Methods: We propose a Personalized Habitat-aware Survival Prediction Network (PHSP-Net) that integrates multiparametric MRI with an adaptive habitat partitioning strategy. The network combines deep convolutional feature extraction and interpretable visualization modules to perform patient-specific subregional segmentation and survival prediction. A total of 1084 patients with histologically confirmed WHO grade IV GBM from four centers (UPENN-GBM, UCSF-PDGM, LUMIERE and TCGA-GBM) were included. PHSP-Net was compared with conventional radiomics, habitat imaging models and ResNet10, with independent validation on two external cohorts.

Results: PHSP-Net achieved an AUROC of 0.795 (95% CI: 0.731-0.852) in the internal validation set, and 0.707 and 0.726 in the LUMIERE and TCGA-GBM external test sets, respectively-outperforming both comparison models. Kaplan-Meier analysis revealed significant OS differences between predicted high- and low-risk groups (log-rank p < 0.05). Visualization analysis indicated that necrotic-region habitats were key prognostic indicators.

Conclusions: PHSP-Net demonstrates high predictive accuracy, robust cross-center generalization and improved interpretability in multi-center GBM cohorts. By enabling personalized habitat visualization, it offers a promising non-invasive tool for prognostic assessment and individualized clinical decision making in GBM.

php - net:使用多参数MRI进行多中心胶质母细胞瘤生存预测的个性化栖息地感知深度学习。
背景:胶质母细胞瘤(GBM)是一种高度侵袭性和异质性的中枢神经系统原发性恶性肿瘤,中位总生存期(OS)约为15个月。实现跨多中心设置的准确和可推广的OS预测对于临床应用至关重要。方法:我们提出了一个个性化的栖息地感知生存预测网络(PHSP-Net),该网络将多参数MRI与自适应栖息地划分策略相结合。该网络结合深度卷积特征提取和可解释的可视化模块来执行针对患者的分区域分割和生存预测。共纳入来自四个中心(UPENN-GBM、UCSF-PDGM、LUMIERE和TCGA-GBM)的1084例组织学证实的WHO IV级GBM患者。将php - net与常规放射组学、栖息地成像模型和ResNet10进行比较,并在两个外部队列中进行独立验证。结果:php - net在内部验证集中的AUROC为0.795 (95% CI: 0.731-0.852),在LUMIERE和TCGA-GBM外部测试集中的AUROC分别为0.707和0.726,优于两种比较模型。Kaplan-Meier分析显示,预测的高危组和低危组的OS差异显著(log-rank p < 0.05)。可视化分析表明,坏死区生境是预测预后的关键指标。结论:php - net在多中心GBM队列中具有较高的预测准确性,稳健的跨中心泛化和改进的可解释性。通过实现个性化栖息地可视化,它为GBM的预后评估和个性化临床决策提供了一种有前途的非侵入性工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bioengineering
Bioengineering Chemical Engineering-Bioengineering
CiteScore
4.00
自引率
8.70%
发文量
661
期刊介绍: Aims Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal: ● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings. ● Manuscripts regarding research proposals and research ideas will be particularly welcomed. ● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material. ● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds. Scope ● Bionics and biological cybernetics: implantology; bio–abio interfaces ● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices ● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc. ● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology ● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering ● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation ● Translational bioengineering
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信